Bifurcation ABSORB OCT Trial

NAUnknownINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

March 31, 2020

Study Completion Date

March 31, 2020

Conditions
Myocardial IschemiaIschemiaCoronary DiseaseHeart DiseasesCardiovascular DiseasesCoronary Bifurcation LesionsArterial Occlusive LesionsInfarctionMyocardial InfarctionArteriosclerosis
Interventions
DEVICE

ABSORB BVS

Trial Locations (1)

1105AZ

Academic Medical Center, Amsterdam

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Abbott Medical Devices

INDUSTRY

lead

J.J. Wykrzykowska

OTHER

NCT02928198 - Bifurcation ABSORB OCT Trial | Biotech Hunter | Biotech Hunter